Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

40%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Other(1)

Detailed Status

Completed3

Terminated1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (33.3%)

N/A2 (66.7%)

Trials by Status

terminated120%

unknown120%

completed360%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC

NCT02738723

completednot_applicable

Effect of Combined Therapy on Neglect Syndrome in Stroke Patients

NCT00784706

Clinical Trials (5)

Showing 5 of 5 trials

NCT04405544Not Applicable

Determination of Acute Encephalopathy Predictors in Patients With COVID-19

MediGuide Registry

Electrocardiogram (ECG) Recordings in Paediatric Population

Completed

NCT02738723Phase 2

SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC

Unknown

NCT00784706Not Applicable

Effect of Combined Therapy on Neglect Syndrome in Stroke Patients

Completed

All 5 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 5